Ceretas LtdASX: CTS

AGM - CEO's Letter to Shareholders

· Issued by Ceretas Ltd via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Ceretas Ltd has released a letter from the CEO to shareholders ahead of its Annual General Meeting, highlighting significant progress since its IPO earlier this year. Additionally, the CEO emphasizes the company's strong financial position and ongoing development of its therapeutic ultrasound technology.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX Announcement CEO’s Letter to Shareholders Brisbane, Australia, 20 November 2026 – Ceretas Limited (ASX:CTS) (“Ceretas” or “the Company”), an Australian medical technology company developing a portable, non-invasive therapeutic ultrasound platform to treat Alzheimer’s disease and...

Ceretas Ltd on 6ix

Earlier from Ceretas

Later from Ceretas

All Ceretas news releases